藤田保健衛生大学　産科・婦人科

原著論文(英文)

• Miyazaki J, Ito M, Nishizawa H, Kato T, Minami Y, Inagaki H, Ohye T, Miyata M, Boda H, Kiriyama Y, Kuroda M, Sekiya T, Kurahashi H, Fujii T. Intragenic duplication in the PKHD1 gene in autosomal recessive polycystic kidney disease. BMC Med Genet. 16:98, 2015.
• Matsumoto K, Maeda H, Oki A1, Takatsuka N, Yasugi T, Furuta R, Hirata R, Mitsuhashi A, Kawana K, Fujii T, Iwata T, Hirai Y, Yokoyama M, Yaegashi N, Watanabe Y, Nagai Y, Yoshikawa H; Japan HPV and Cervical Cancer (JHACC) Study Group. Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis? Cancer Sci. 106(10):1448-1454, 2015.
• Sago H, Sekizawa A; Japan NIPT consortium. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: one-year experience. Prenat Diagn. 35:1-6, 2015
• Iwata T, Fujii T, Morii K, Saito M, Sugiyama J, Nishio H, Morisada T, Tanaka K, Yaguchi T, Kawakami Y, Aoki D. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. Int J Clin Oncol. 20(1):126-33, 2015
• Minami Y, Sekiya T, Nishizawa H, Miyazaki J, Noda Y, Ishii R, Yasue A, Nishio E, Udagawa Y, Fujii T. Relationship between detection of the cervical gland area during the late third trimester and necessity for induction of labor to prevent post-term delivery. J Med Ultrasonics. 41(4):463-471, 2014
• Komatsu H, Yagasaki K, Shoda R, Chung Y, Iwata T, Sugiyama J, Fujii T. Repair of the threatened feminine identity: experience of women with cervical cancer undergoing fertility preservation surgery. Cancer Nursing. 37(1): 75-82, 2014
• Ichikawa R, Torii Y, Oe S, Kawamura K, Kato R, Hasegawa K, Udagawa Y. Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma. Arch Gynecol Obstet. 290(5):979-84, 2014
• Fujii T, Saito M, Hasegawa T, Iwata T, Kuramoto H, Kubushiro K, Ohmura M, Ochiai K, Arai H, Sakamoto M, Motoyama T, Aoki D. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study. Int J Clin Oncol. 20(1):134–142, 2014
• Nakamura M, Fujii T, Imanishi N, Jinzaki M, Yamada M, Kuribayashi S, Aoki D. Surgical anatomy imaging associated with cervical cancer treatment: A cadaveric study. Clin Anat. 27(3):503-10, 2014
• Tsutsumi M, Fujiwara R, Nishizawa H, Ito M, Kogo H, Inagaki H, Ohye T, Kato T,Fujii T, Kurahashi H. Age-related decrease of meiotic cohesins in human oocytes. PLoS One. 7;9(5):e96710, 2014
• Torii Y, Kato R, Minami Y, Hasegawa K, Fujii T, Udagawa Y. ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells. Anticancer Res. 34(1):107-15, 2014.
• Fujii T, Takatsuka N, Nagata C, Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Kawana K, Mitsuhashi A, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H: Association between carotenoids and outcome of cervical intraepithelial neoplasia : a prospective cohort study. Int J Clin Oncol, 2013;18(6): 1091-101
• Satoh T, Matsumoto K, Fujii T, Sato O, Gemma N, Onuki M, Saito H, Aoki D, Hirai Y, Yoshikawa H: Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test ( Clinichip HPVTM ). J Virol Methods, 188(1-2) : 83-93, 2013
• Nishio H, Fujii T, Sugiyama J, Kuji N, Tanaka M, Hamatani T, Miyakoshi K, Minegishi K, Tsuda H, Iwata T, Tanaka K, Fukuchi T, Takehara Y, Yoshimura Y, Aoki D: Reproductive and obstetric outcomes after radical abdominal trachelectomy for early-stage cervical cancer in a series of 31 pregnancies. Hum Reprod, 28(7): 1793-98, 2013
• Nishio S, Fujii T, Nishio H, Kameyama K, Saito M, Iwata T, Kubushiro K, Aoki D: P16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping. J Gynecol Oncol, 24(3): 215-21, 2013
• Kataoka F, Nomura H, Nogami Y, Arima H, Sawano Y, Banno K, Fujii T, Aoki D: Evaluation of clinical usefulness of a medizal monitor equipped with an Oorganic electroluminescence panel in comparison with liquid crystal display monitors. J Minim Invasive Gynecol, 20(4): 522-28, 2013
• Murakami I, Fujii T, Dan K, Saito M, Ohno A, Iwata T, Aoki D: Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia. J Clin Virol, 58(1): 149-54, 2013
• Chen Y, Miyazaki J, Nishizawa H, Kurahashi H, Leach R, Wang K. MTA3 regulates CGB5 and Snail genes in trophoblast. Biochem Biophys Res Commun 433:379-384, 2013
• Achiwa Y, Hasegawa K, Udagawa Y. Effect of ursolic acid on MAPK in cyclin D1 signaling and RING-type E3 ligase (SCF E3s) in two endometrial cancer cell lines. Nutr Cancer. 65(7):1026-33, 2013.
• Hasegawa K, Minami Y, Inuzuka H, Oe S, Kato R, Tsukada K, Udagawa Y, Kuroda M. Female pseudohermaphroditism associated with maternal steroid cell tumor, not otherwise specified of the ovary: a case report and literature review. Clin Exp Obstet Gynecol. 40(4):591-5, 2013.
• Kato R, Hasegawa K, Ishii R, Owaki A, Torii Y, Oe S, Hirasawa H, Kobayashi Y, Udagawa Y: Human epidermal growth factor receptor-2 overexpression and amplification in metastatic and recurrent high grade or type 2 endometrial carcinomas. Onco Targets Ther. 6: 1065-1071, 2013.
• Inuzuka H. Nishizawa H. Inagaki A, Suzuki M, Ota S, Miyamura H, Miyazaki J, Sekiya T, Kurahashi H, Udagawa Y: Decreased expression of apelin in placentas from severe pre-eclampsia patients. Hypertens Pregnancy. 32(4):410-21, 2013.
• Ota S, Miyamura H,Nishizawa H, Inagaki H, Inagaki A, Inuzuka H, Suzuki M, Miyazaki J, Sekiya T, Udagawa Y, Kurahashi H. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia. Placenta. 34(12):1202-1210, 2013.
• Hasegawa K, Ishikawa K, Kawai S, Torii Y, Kawamura K, Kato R, Tsukada K, Udagawa Y. Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor. Oncol Rep. 30(6):2937-44, 2013.
• Kotsuji F, Nishijima K, Kurokawa T, Yoshida Y, Sekiya T, Banzai M, Minakami H, Udagawa Y: Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. BJOG. 120(9): 1144-1149, 2013.
• Yoshihara K, Tsunoda T, Shigemizu D, Fujiwara H, Hatae M, Fujiwara H, Masuzaki H, Katabuchi H, Kawawkami Y, Okamoto A, Nogawa T, Matsumura N, Udagawa Y, Saito T, Itamochi H, Takano M, Miyagi E, Sudo T, Ushijima K, Iwase H, Seki H, Terao Y, Enomoto T, Mikami M, Akazawa K, Tsuda H, Moriya T, Tajima A, Inoue I, Tanaka K: High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by down-regulation of antigen presentation pathway. Clinical Cancer Research. 18(5): 1374-1385, 2012.
• Hasegawa K, Okamoto H, Kawamura K, Kato R, Kobayashi Y, Sekiya T, Udagawa Y: The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix. European Fournal of Obstetrics & Gynecology and Reproductive Biology. 163(1): 67-70, 2012.
• Hasegawa K, Kawamura K, Kato R, Komiyama S, Kaneko C, Udagawa Y: The Effects of the Selective Cyclooxygenase-2 Inhibitor on Endometrial Cytological Findings in Uterine Endometrial Cancer Patients. Acta Cytol. 56(4): 394-400, 2012.
• Inagaki A, Nishizawa H, Ota S, Suzuki M, Inuzuka H, Miyamura H, Sekiya T, Kurahashi H, Udagawa Y: Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia. Placenta. 33(11): 919-926, 2012.
• Komiyama S, Nishio E, Ichikawa R, Miyamura H, Kawamura K, Komiyama M, Nishio Y, Udagawa Y: Asymptomatic synchronous quintuple primary cancers. Gynecol Obstet Invest. 74(4): 324-328, 2012.
• Yanoh K, Hirai Y, Sakamoto A, Aoki D, Moriya T, Hiura M, Yamawaki T, Shimizu K, Nakayama H, Sasaki H, Tabata T, Ueda M, Udagawa Y, Norimatsu Y: New terminology for intrauterine endometrial samples: a group study by the Japanese Society of Clinical Cytology. Acta Cytologica. 56(3): 233-241, 2012.
• Miyamura H, Nishizawa H, Ota S, Suzuki M, Inagaki A, Egusa H, Nishiyama S, Kato T, Pryor-Koishi K, Nakanishi I, Fujita T, Imayoshi Y, Markoff A, Yanagihara I, Udagawa Y, Kurahashi H: Polymorphisms in the annexin A5 gene promoter in Japanese women with recurrent pregnancy loss. Molecular Human Reproduction. 17(7): 447-452, 2011.
• Nishio E, Hirota Y, Yasue A, Nishizawa H, Tsukada K, Udagawa Y: Two cases of ectopic ovary and one case of potential ectopic ovary. Reproductive Medicine and Biology. 10(1): 51-54, 2011.
• Nishiyama S, Kishi T, Kato T, Suzuki M, Bolor H, Nishizawa H, Iwata N, Udagawa Y, Kurahashi H: A rare synaptonemal complex protein 3 gene variant in unexplained female infertility. Molecular Human Reproduction. 17(4): 266-271, 2011.
• Shiraishi H, Ikemoto K, Tada S, Udagawa Y, Ohtsuki M, Sumi-Ichinose C, Kondo K, Nomura T: Cilostazol Inhibits Cytokine-Induced Tetrahydrobiopterin Biosynthesis in Human Umbilical Vein Endothelial Cells. Journal of Atherosclerosis and Thrombosis. 18(4): 312-317, 2011.
• Komiyama S, Kurahashi T, Ishikawa M, Tanaka K, Komiyama M, Mikami M, Udagawa Y : Expression of TGFβ1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin. Oncology Reports. 25(4): 1131-1138, 2011.
• Yasue A, Hasegawa K, Udagawa Y: Effects of Tamoxifen on the endometrium and its mechanism of carcinogenicity. Human Cell. 24(2): 65-73, 2011.
• Miyata M, Hasegawa K, Ishikawa K, Kato R, Udagawa Y, Kuroda M: Primary myoepithelial carcinoma of the vulva and review of the literature. J Obstet Gynaecol Res. 37(6): 617-622, 2011.
• Shibata M, Suzuki A, Sekiya T, Sekiguchi S, Asano S, Udagawa Y, Itoh M: High prevalence of hypovitaminosis D in pregnant Japanese women with threatened premature delivery. Journal of Bone and Mineral Metabolism. 29(5): 615-620, 2011.
• Nishizawa H, Suzuki M, Pryor-Koishi K, Sekiya T, Tada S, Kurahashi H, Udagawa Y: Impact of indoleamine 2,3-dioxygenase on the antioxidant system in the placentas of severely pre-eclamptic patients. Systems Biology in Reproductive Medicine. 57(4): 174-178, 2011.
• Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, Kurahashi H, Udagawa Y: Comparative gene expression profiling of placentas from patients with severe pre-eclampsia andunexplained fetal growth restriction. Reproductive Biology and Endocrinology. 9: 1-12, 2011.
• Komiyama S, Nishio E, Torii Y, Kawamura K, Oe S, Kato R, Hasegawa K, Abe M, Kuroda M, Udagawa Y: A case of primary uterine cervical neuroendocrine tumor with meningeal carcinomatosis confirmed by diagnostic imaging and autopsy. Int J Clin Oncol. 16(5): 581-586, 2011.
• Hasegawa K, Kato R, Torii Y, Ichikawa R, Oe S, Udagawa Y: The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO StageⅠto StageⅡ Uterine Cervical Adenocarci noma. International Journal of Gynecological Cancer. 21(8): 1479-1485, 2011.
• Tada S, Yasue A, Nishizawa H, Sekiya T, Hirota Y, Udagawa Y: Spontaneous spinal epidural hematoma during pregnancy: Three case reports. Journal of Obstetrics and Gynaecology Research. 37(11): 1734-1738, 2011.
• Hasegawa K, Torii Y, Ishii R, Oe S, Kato R, Udagawa Y: Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers. Arch Gynecol Obstet. 284(6): 1515-1521, 2011.
• Hasegawa K, Ichikawa R, Ishii R, Oe S, Kato R, Kobayashi Y, Kuroda M, Udagawa Y: A case of primary alveolar soft part sarcoma of the uterine cervix and a review of the literature. Int J Clin Oncol. 16(6): 751-758, 2011.
• Kato R, Hasegawa K, Achiwa Y, Olamoto H, Torii Y, Oe Y, Udagawa Y: Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay. Eur J Gynaec Oncol. 32(4): 381-386, 2011.
• Komiyama S, Aoki D, Saitoh E, Komiyama M, Udagawa Y: Biological significance of plasminogen activator inhibitor-1 expression in ovarian clear cell adenocarcinoma. Eur J Gynaec Oncol. 32(6): 611-614, 2011.
• Sekiya T, Murotsuki J, Nishizawa H, Udagawa Y: Ultrasonic Diagnosis of Fetal Bone and Small Parts. Donald School Journal of Ultrasound in Obstetrics and Gynecology. 5(1): 45-55, 2011.
• Nagase S, Inoue Y, Umesaski N, Aoki D, Ueda M, Sakamoto H, Kobayashi S, Kitagawa R, Toita T, Nagao S, Hasegawa K, Fukasawa I, Fujiwara K, Watanabe Y, Ito K, Niikura H, Iwasaka T, Ochiai K, Katabuchi H, Kamura T, Konishi I, Sakuragi N, Tanaka T, Hirai Y, Hiramatsu Y, Mukai M, Yoshikawa H, Takano T, Yoshinaga K, Otsuki T, Sakuma M, Inaba N, Udagawa Y, Yaegashi N: Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition. Int J Clin Oncol. 15(2): 117-124, 2010.
• Nishizawa H, Kato T, Ota S, Nishiyama S, Pryor-Koishi K, Suzuki M, Tsutsumi M, Inagaki H, Kurahashi H, Udagawa Y: Genetic Variation in the Indoleamine 2,3-Dioxygenase Gene in Pre-eclampsea. American Journal of Reproductive Immunology. 64(1): 68-76, 2010.
• Nishiyama S, Hirota Y, Nishizawa H, Tada S, Udagawa Y: Bilateral Interruption of Mid-Fallopian Tubes and Ovarian Anomalies Including Ectopic Ovary and Cysitic Teratoma, a Previously Unreported Combination. The Journal of Minimally Invasive Gynecology. 17(4): 534-537, 2010.
• Oe S, Hasegawa K, Nagase S, Kato R, Torii Y, Udagawa Y: Expression of podoplanin in epithelial ovarian carcinomas and its potential as a marker for clear cell adenocarcinoma. International Journal of Gynecological Pathologists. 29(5): 405-410, 2010.
• Kaneko C, Tadao K. Kobayahi, Hasegawa K, Udagawa Y, Iwai M: A Cell-Block Preparation Using Glucomannan Extracted From Amorphophallus Konjac. Diagnostic Cytopathology. 38(9): 652-656, 2010.
• Takano M, Sugiyama T, Yaegashi N, Sagae S, Kuzuya K, Udagawa Y, Tsuda H, Suzuki M, Kigawa J, Goto T, Tsuda H, Moriya T, Kikuchi Y: Less impact of adjuvant chemotherapy for stageⅠclear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study. International Journal of Gynecologic Cancer. 20(9): 1506-1510, 2010.
• Nagase S, Katabuchi H, Hiura M, Sakuragi N, Aoki Y, Kigawa J, Saito T, Hachisuga T, Ito K, Uno T, Katsumata N, Komiyama S, Susumu N, Emoto M, Kobayashi H, Metoki H, Konishi I, Ochiai K, Mikami M, Sugiyama T, Mukai M, Sagae S, Hoshiai H, Aoki D, Ohmichi M, Yoshikawa H, Iwasaka T, Udagawa Y, Yaegashi N: Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition. Int J Clin Oncol. 15(6): 531-542, 2010.
• Bolor H, Mori T, Nishiyama S, Ito Y, Inagaki H, Kogo H, Ohye T, Tsutsumi T, Kato T, Tong M, Nishizawa H, Pryor-Koishi K, Kitaoka E, Sawada T, Nishiyama Y, Udagawa Y, Kurahashi H: Mutations of the SYCP3 Gene in Women with Recurrent Pregnancy Loss. The American Journal of Human Genetics. 84(1): 14-20, 2009.
• Sekiya T, Nishizawa H, Ozawa N, Tada S, Hasegawa K, Hirota Y, Katoh R, Bannno T, Udagawa Y: Clinical features and characteristics of blood flow of uterine vascular abnormalities. Journal of MEDICAL ULTRASONICS. 36(1): 19-26, 2009.
• Aoki D, Watanabe Y, Jobo T, Ushijima K, Hasegawa K, Susumu N, Suzuki N, Aoki R, Isonishi S, Sagae S, Ishizuka B, Kamura T, Udagawa Y, Hoshiai H, Ohashi Y, Ochiai K, Noda K: Favourable Prognosis with Modified Dosing of Docetaxel and Cisplatin in Japanese Patients with Ovarian Cancer. Anticancer Research. 29(2): 561-566, 2009.
• Nishizawa H, Pryor-Koishi K, Suzuki M, Kato T, Sekiya T, Tada S, Kurahashi H, Udagawa Y: Analysis of Nitric Oxide Metabolism as a Placental or Maternal Factor Underlying the Etiology Pre-Eclampsia. Gynecologic and Obstetric Investigation. 68(4): 239-247, 2009.
• Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Kikuchi Y: The Impact of Complete Surgical Staging Upon Survival in Early-Stage Ovarian Clear Cell Carcinoma. International Journal of Gynecological Cancer. 19(8): 1353-1357, 2009.
• Nishiyama S, Kishi T, Kato T, Suzuki M, Nishizawa H, Pryor-Koishi K, Sawada T, Nishiyama Y, Iwata N, Udagawa Y, Kurahashi H: CD9 Gene Variations Are Not Associated with Female Infertility in Humans. Gynecol Obstet Invest. 69(2): 116-121, 2009.
• Ohmori T, Nakamura M, Tada S, Sugiyama T, Udagawa Y: A highly sensitive assay for ritodrine in human serum by hydrophilic interaction chromatograpy-tandem  mass spectrometry. JOURNAL OF CHROMATOGRAPHY B. 861(1): 95-100, 2008.
• Nishizawa H, Hasegawa K, Suzuki M, Achiwa Y, Kato T, Saito K, Kurahashi H, Udagawa Y: Mouse model for allogeneic immune reaction against fetus recapitulates human pre-eclampsia. J Obstet Gynaecol Res. 34(1): 1-6, 2008.
• Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, Kudo R: Randomized phase Ⅲ trial of pelvic radiotherapy versus cisplatin-based combined chemorherapy in patients with Intermediate- and high-risk endometrial cancer. : A Japanese Gynecologic Oncology Group study. Gynecologic Oncology. 108(2008): 226-233. 2008.
• Nishiyama S, Hirota Y, Kato R, Hayakawa N, Tukada K, Udagawa Y: Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary. Med Sci Monit. 14(2): 9-12, 2008.
• Susumu N, Sagae S, Udagawa Y: Reply to Michael H.R. Eichbaum et al. “Adjuvant treatment of early- stage endometrial cancer : Which patient can benefit from chemotherapy?”. Gynecologic Oncology. 109(3): 434-436, 2008.
• Ikemoto K, Matsumoto T, Ohtsuki M, Itoh M, Tada S, Udagawa Y, Sumi-Ichinose C, Kondo K, Nomura T: 2,4-Diamino-6-hydroxypyrimidine  (DAHP) suppresses cytokine-induced VCAM-1 expression on the cell surface of human umbilical vein endothelial cells in a BH4-independent manner. Biochimica et Biophysica Acta (BBA). 1780(7-8): 960-965, 2008.
• Nishizawa H, Pryor-Koishi K, Suzuki M, Kato T, Kogo H, Sekiya T, Kurahashi H, Udagawa Y: Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Molecular Human Reproduction. 14(10): 595-602, 2008.
• Hirai Y, Banno K, Suzuki M, Ichikawa Y, Udagawa Y, Suano K, Miki Y: Molecular epidemiological and mutational analysis of DNA Mismatchi repair (MMR) genes in endometrial cancer patients with HNPCC-asociated familial predisposition to cancer. Cancer Sci. 99(9): 1715-1719, 2008.
• Achiwa Y, Hasegawa K, Udagawa Y: Regulation of the phosphatidylinositol  3-Kinase-Akt and the Mitogen-Activated Protein Kinase Pathways by Ursolic Acid in Human Endometrial Cancer Cells. Biosci Biotechnol Biochem. 71(1): 31-37, 2007.
• Kanasugi M, Aoki D, Suzuki N, Susumu N, Nakata S, Horiuchi M, Nozawa S, Udagawa Y: Sensitivity to cisplatin determined by the histoculture drug response assay andclinical response of endometrial cancer. Int J Gynecol Cancer. 16(1): 409-415, 2006.
• Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y: Microarray Analysis of Differentially Expressed Fetal Genes in Placental Tissue Derived form Early and Late Onset Severe Pre-eclampsia. PLACENTA. 28(5-6): 487-497, 2007.
• Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Moriya T, Kikuchi Y: Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin : retrospective analysis. Int J Clin Oncol. 12(4): 256-260, 2007.
• Nishizawa H, Hasegawa K, Suzuki M, Kamoshida S, Saito K, Tsutsumi Y, Kato T, Kurahashi H, Udagawa Y: The Etiological Role of Allogeneic Fetal Rejection in Pre-Eclampsia. American Journal of Reproductive Immunology. 58(1): 11-20, 2007.
• Pryor-Koishi K, Nishizawa H, Kato T, Kogo H, Murakami T, Tsuchida K, Kurahashi H, Udagawa Y: Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia. BJOG. 114(9): 1128-1137, 2007.
• Nishio E, Moriwaki T, Yoshii K, Udagawa Y: Chemical removal of zona pellucida versus laser assisted hatching after repeated failures of assisted reproductive technology. Reproductive Medicine and Biology. 5(4): 263-267, 2006.
• Takano M, Kikuchi Y, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T: Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary. Oncol Reports. 16: 1301-1306, 2006.
• Nakada S, Aoki D, Ohie S, Horiuchi M, Suzuki N, Kanasugi M, Susumu N, Udagawa Y, Nozawa S: Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response. Intl J Gynec Cancer. 15: 445-452, 2005.
• Hasegawa K, Ohashi Y, Ishikawa K, Yasue A, Kato R, Achiwa Y, Nishio E, Udagawa Y: Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Intl J Oncol. 26: 1419-1428, 2005.
• Achiwa Y, Hasegawa K, Udagawa Y: Molecular mechanism of ursolic acid induced apoptosis in poorly differentiated endometrial cancer HEC108 cells. Oncol Reports. 14: 507-512, 2005.
• Saito M, Aoki D, Susumu N, Suzuki A, Suzuki N, Udagawa Y, Nozawa S: Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546. Intl J Gynec Cancer. 15: 37-44, 2005.
• Hirota Y, Tsukada K, Nishio E, Yoshida M, Tada S, Udagawa Y: Postoperative Adhesion Formation After Laparoscopic Uterine Horn Resection in a Porcine Model: Comparison of Five Instruments. Journal of Laparoendoscopic ＆ Advanced Surgical Techniques. 15(6): 581-585, 2005.
• Banno K, Susumu N, Hirao T, Yanokura M, Hirasawa A, Aoki D, Udagawa Y, Sugano K, Nozawa S: Two Japanese kindreds occurring endometrial cancer meeting new clinical criteria for hereditary non- polyposis colorectal cancer (HNPCC), Amsterdam CriteriaⅡ. J Obstet Gynaecol Res. 30(4): 287-292, 2004.
• Kuroki J, Hasegawa K, Kato R, Mizukawa J, Nishio E, Nishizawa H, Udagawa Y: Relationship between the classification of vascular invasion severity and the prognosis of uterine endometrial cancer. Intl J Gynec Cancer. 13: 47-52, 2003.
• Saitoh E, Aoki D, Susumu N, Udagawa Y, Nozawa S: Galactosyltransferase associated with tumor in patients with ovarian cancer: Factors involved in elevation of serum galactosyltransferase. Intl J Oncol. 23: 303-310, 2003.
• Banno K, Susumu N, Hirao T, Yanokura M, Hirasawa A, Aoki D, Udagawa Y, Sugano K, Nozawa S: Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer. Cancer Genetics and Cytogenetics. 146(1): 58-65, 2003.
• Hasegawa K, Suzuki M, Ishikawa K, Yasue A, Kato R, Nakamura A, Kuroki J, Udagawa Y: Establishment and characterization of a human uterine endometrial undifferentiated carcinoma cell line, TMG-L. HUMAN CELL. 16(1): 31-38, 2003.
• Shiraishi H, Kato T, Atsuta K, Sumi-Ichinose C, Ohtsuki M, Itoh M, Hishida H, Tada S, Udagawa Y, Nagatsu T, Hagino Y, Ichinose H, Nomura T: cGMP Inhibits GPT Cyclohydrolase I Activity and Biosynthesis of Tetrahydrobiopterin in Human Umbilical Vein Endothelial Cells. J Pharmacol Sci. 93:265-271, 2003.
• Ohtsuki M, Shiraishi H, Kato T, Kuroda R, Tazawa M, Sumi-Ichinose M, Tada S, Udagawa Y, Itoh M, Hishida H, Ichinose H, Nagatsu T, Hagino Y, Nomura T: cAMP inhibits cytokine- induced biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells. Life Scienses. 70: 2187-2198, 2002.
• Ohashi M, Yoshikawa T, Ihira M, Suzuki K, Suga S, Tada S, Udagawa Y, Sakui H, Iida K, Saito Y, Nisiyama Y, Asano Y: Reactivation of Human Herpesvirus 6 and 7 in Pregnant Women. Journal of Medical Virology. 67: 354-358, 2002.
• Kudo G, Toyama H, Hasegawa K, Kurodda M, Hattori H, Ishiguro M, Kato M, Sawai T, Ejiri K, Minami K, Udagawa Y, Katada K: Sentinel Lymph Node Navigation Surgery in Paget,s Disease of the Vulva. Clinical Nuclear Medicine. 27(12): 909-910, 2002.
• Hirota Y, Ohara S, Nishizawa H, Tada S, Udagawa Y: Evaluation of laparoscopic management and clinical outcome in women with premature ovarian failure. Gynaecological Endoscopy. 11: 411-415, 2002.
• Sawada T, Tsukada K, Hasegawa K, Ohashi Y, Udagawa Y: Victor Gomel: Cross-Iinked hyaluronate hydrogel prevents adhesion formation and reformation in mouse uterine horn model. Human Reproduction. 16(2): 353-356, 2001.